Nasal hyperreactivity to methacholine measured by acoustic rhinometry in asymptomatic allergic and perennial nonallergic rhinitis.
This study was carried out to assess nasal response to different doses of methacholine and to evaluate the diagnostic possibilities of this test. Thirty-seven patients with allergic rhinitis induced by pollen (out of season), 16 with nonallergic rhinitis, and 25 normal subjects were evaluated. After provocation with saline, increasing doses of methacholine, ranging from 0.5 to 16 mg/mL, were applied. Nasal obstruction was assessed by acoustic rhinometry 10 minutes after each dose, the minimum cross-sectional area and the nasal volume in both fossae were obtained. Ipratropium bromide was applied after the last dose of methacholine to evaluate reversibility. After methacholine challenge with 0.5, 1, 2, and 4 mg/mL there was a statistically significant decrease (p < 0.05) in nasal area and volume in a dose-dependent manner in patients with allergic and nonallergic rhinitis in comparison with controls. A ROC (receiver-operating characteristic) analysis showed that a decrease in nasal volume > or = 20% at methacholine concentration of 2 mg/mL is able to predict the presence of rhinitis (positive predicted value 93%, negative predicted value 79%) in 75% of subjects. The clinical relevance of this finding suggests that patients with symptomatic nonallergic rhinitis or even asymptomatic patients with allergic rhinitis out of pollen season present a nasal hyperreactivity to methacholine, and that a decrease of nasal volume > 20% by acoustic rhinometry after challenge with methacholine at 2 mg/mL is able to discriminate these patients from normal subjects. This method seems to be a suitable tool in the diagnosis of rhinitis.
Márquez
F
F
Allergy Department, Fundación Jiménez Díaz, Madrid, Spain.
Sastre
J
J
Hernández
G
G
Cenjor
C
C
Sanchez-Hernandez
J M
JM
Sánchez
J
J
Gutiérrez
R
R
Sanabria
J
J
D000162:Acoustics; D016085:Bronchoconstrictor Agents; D016022:Case-Control Studies; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016210:Methacholine Chloride; D009296:Nasal Cavity / Q000166:cytology / Q000276:immunology*; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis* / Q000276:immunology; D012680:Sensitivity and Specificity
D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride